Ben Lightburn, Co-Founder & CEO, Filament Health
Professionally Cannabis and Psychedelics
English - May 18, 2022 14:00 - 27 minutes - 19 MB - ★★★★★ - 4 ratingsAlternative Health Health & Fitness Medicine cannabis weed marijuana business investing pot potstocks cannabiz psychedelics psychedelic Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Terry Booth, CEO of Audacious
Next Episode: Niklas Kouparanis, Co-Founder & CEO of Bloomwell Group
Tune into today’s podcast to hear from Ben Lightburn, the Co-Founder & CEO of Filament Health.
Listed on the NEO Exchange, Filament Health have many irons in the psychedelic fire, spearheading clinical trials (alongside the University of California, San Francisco), registering a whole host of IP and making strides forward within drug discovery. As a company that favours naturally derived psychedelics, rather than their synthetic counterparts, this is a must listen for anyone with a keen eye on psychedelic medicine!
Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/